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Abstract
Background: The zoonotic pathogen Campylobacter jejuni is a leading cause of bacterial foodborne enterocolitis in humans
worldwide. The understanding of immunopathology underlying human campylobacteriosis is hampered by the fact that
mice display strong colonization resistance against the pathogen due to their host specific gut microbiota composition.
Methodology/Principal Findings: Since the microbiota composition changes significantly during intestinal inflammation
we dissected factors contributing to colonization resistance against C. jejuni in murine ileitis, colitis and in infant mice. In
contrast to healthy animals C. jejuni could stably colonize mice suffering from intestinal inflammation. Strikingly, in mice
with Toxoplasma gondii-induced acute ileitis, C. jejuni disseminated to mesenteric lymphnodes, spleen, liver, kidney, and
blood. In infant mice C. jejuni infection induced enterocolitis. Mice suffering from intestinal inflammation and C. jejuni
susceptible infant mice displayed characteristical microbiota shifts dominated by increased numbers of commensal
Escherichia coli. To further dissect the pivotal role of those distinct microbiota shifts in abrogating colonization resistance,
we investigated C. jejuni infection in healthy adult mice in which the microbiota was artificially modified by feeding live
commensal E. coli. Strikingly, in animals harboring supra-physiological intestinal E. coli loads, colonization resistance was
significantly diminished and C. jejuni infection induced enterocolitis mimicking key features of human campylobacteriosis.
Conclusion/Significance: Murine colonization resistance against C. jejuni is abrogated by changes in the microbiota
composition towards elevated E. coli loads during intestinal inflammation as well as in infant mice. Intestinal inflammation
and microbiota shifts thus represent potential risk factors for C. jejuni infection. Corresponding interplays between C. jejuni
and microbiota might occur in human campylobacteriosis. Murine models introduced here mimick key features of human
campylobacteriosis and allow for further analysis of immunological and molecular mechanisms of C. jejuni – host
interactions.
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Introduction
Campylobacter (C.) jejuni continues to be the most frequently
reported causative agent of bacterial gastroenteritis in humans
worldwide [1,2]. The gram-negative bacteria form part of the
commensal flora in many wild and domestic animals. Zoonotic
transmission from livestock animals via consumption of contam-
inated meat products is the most common source for human
C. jejuni infections [3,4,5]. Infected patients present a broad range
of symptoms including abdominal pain, watery or bloody
diarrhea, and fever. Histological examination of affected intestinal
tissues commonly reveals crypt abscesses, ulcerations, and elevated
numbers of immune cells in the colon in situ [6,7,8,9]. Although
the infection is self-limiting in most cases, long-term sequelae such
as reactive arthritis, gastrointestinal and neurological disorders
have been reported in susceptible hosts [10,11]. C. jejuni infection
correlates with reactivation of inflammatory bowel diseases (IBD),
Miller-Fisher-Syndrome and Guillian-Barre ´-Syndrome [10,11].
The high prevalence of campylobacteriosis poses a significant
health burden and accentuates the need for further unravelling the
underlying pathogenesis of C. jejuni infections. The lack of
understanding mainly stems from the scarcity of suitable
experimental in vivo models of human infection [12]. Although
chickens allow for the investigation of colonization and transmis-
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are absent [12,13]. Murine models of C. jejuni infection have the
disadvantage of sporadic colonization, absence of clinical signs of
disease and/or lack of intestinal immunopathology [6,12]. This is
in part due to the colonization resistance against C. jejuni exhibited
by adult mice older than two months (commonly used in
experimental settings) harboring a conventional intestinal micro-
biota [12]. Results from the 1980s demonstrated that colonization
resistance was abrogated in isolator raised germfree (GF) mice. In
these animals C. jejuni colonized the entire gastrointestinal (GI)
tract and induced clinical signs of enterocolitis including
granulocyte infiltrates, bloody diarrhea, and humoral immune
responses [14,15,16]. More recent investigations showed that
colonization resistance is mainly caused by the host-specific
intestinal microbiota composition [17,18]. Previous work in our
group revealed that colonization resistance of mice against C. jejuni
is abrogated in gnotobiotic (GB) mice generated by quintuple
antibiotic treatment as well as in GB mice replenished with human
flora (hfa) [17]. In contrast to isolator raised germfree mice,
however, GB and hfa animals display a fully established immune
system. The finding that GB mice replenished with murine flora
were completely resistant to C. jejuni proved that colonization
resistance is caused by the host-specific microflora composition
[17]. Most strikingly, C. jejuni infected GB and hfa mice displayed
characteristic inflammatory responses seen in human campylo-
bacteriosis [17]. The major role of the microflora composition in
colonization resistance against C. jejuni was further supported by
the recent finding that obesity caused by both feeding human
‘‘Western style’’ cafeteria diet (CAF) as well as leptin deficiency in
ob/ob
2/2 mice rendered mice susceptible to C. jejuni infection [18].
Interestingly, quantitative analysis of main gut bacterial groups
revealed 2–3 orders of magnitude higher loads of commensal
E. coli in C. jejuni susceptible animals in all these models as a
common feature as compared to respective resistant controls
[17,18]. Recent studies on Salmonella enterica also point towards a
pivotal role of microbiota composition in host susceptibility to
enteropathogenic bacteria [19,20]. Mice displaying high com-
mensal E. coli densities were more susceptible to S. enterica induced
gut inflammation [19,20,21]. We have previously shown that
murine models of acute small as well as large intestinal
inflammation were associated with tremendous changes of the
intestinal microbiota with decreasing species diversity and
lactobacilli loads and an intestinal overgrowth with commensal
E. coli and Bacteroides/Prevotella spp. [22,23,24,25]. We could
further show that TLR-4-signalling of E. coli LPS initiated and
perpetuated acute ileitis and colitis in mice [23,24]. Thus, these
experimental models were mimicking immunopathological key
features of human IBD Crohn’s disease (CD) and ulcerative colitis
(UC). The exact etiology of IBD remains unknown and the
pathogenesis seems to be multifactorial, involving the complex
interaction between the intestinal microflora, host immune and
genetic factors as well as environmental stimuli [26,27], Gram-
negative bacteria such as E. coli and Bacteroides spp. have been
reported to accumulate at inflamed tissue sites in IBD patients with
active intestinal inflammation, and further potentiate immunopa-
thology by translocation via microlesions and ulcerations [28,29].
It is under current debate whether IBD patients might be more
susceptible to intestinal pathogens such as Campylobacter or
Salmonella spp. and whether acute bacterial enterocolitis is one of
the factors inducing or exacerbating IBD in susceptible individuals
[26,27,30]. Results from population-based studies point towards a
potential role of enteric Campylobacter or Salmonella infections in IBD
development [31,32,33].
In the present study, we investigated colonization resistance in
mice displaying an altered gut microbiota composition under
conditions of acute or chronic intestinal inflammation as well as
in infant mice after weaning (lacking signs of intestinal
inflammation) having all elevated intestinal E. coli loads in
common. Finally we asked the question whether feeding healthy
adult mice with live E. coli and thus artificially elevating the
enterobacteria population within the commensal gut microbiota
towards supra-physiological loads might overcome colonization
resistance and renders the animals susceptible to C. jejuni. The
results clearly demonstrate that colonization resistance is
completely abrogated under conditions of elevated E. coli loads
within the commensal intestinal microbiota. Following infection,
C. jejuni induced pro-inflammatory immune responses mimicking
key features of human campylobacteriosis. Taken together, the
murine C. jejuni infection models presented here proved to be
suitable for reproducible investigations of factors that predispose
C. jejuni colonization and trigger the onset and progress of
infection and immunopathology.
Results
T. gondii-induced Acute Ileitis Abrogates Colonization
Resistance of Mice Against C. jejuni Infection
Colonization resistance against C. jejuni exerted by mice
harbouring a conventional intestinal microbiota can be
overcome by modification of the gut microbiota composition.
We therefore investigated C. jejuni infection capacities in mice
with acute or chronic intestinal inflammation displaying distinct
microbiota shifts towards higher intestinal enterobacteria loads.
Three-months-old adult C57BL/6 mice harboring a conven-
tional gut microbiota were infected perorally with T. gondii in
order to induce acute ileitis. Four days thereafter, the time point
when initial histopathological changes in the ileum mucosa can
be observed, mice were orally subjected to 10
9 CFU C. jejuni
ATCC 43431 by gavage. At day 7 following T. gondii infection,
mice suffered from acute ileitis and were prone to death.
Interestingly, by that time (i.e. 3 days following C. jejuni ATCC
43431 infection) C. jejuni ATCC 43431 could be cultured from
the entire GI tract of diseased, but not healthy mice with high
loads of 10
9 CFU/g in duodenum, ileum and colon (Fig. 1A).
Notably, the E. coli concentrations in the ileum lumen had
increased by more than 6 orders of magnitude up to more than
10
10 CFU/g during ileitis development (Fig. 1B). Live C. jejuni
ATCC 43431 and commensal E. coli translocated into MLNs
draining the small intestine (10060% and 78.667.1%, respec-
tively), spleen (57.161.49% and 50.060.68%, respectively) and
liver (57.160% and 42.960%, respectively) (Fig. 1C). Strik-
ingly, in 92.960.68%, but only in 7.160.7% of mice with acute
ileitis following T. gondii infection, live C. jejuni ATCC 43431
and E. coli, respectively, could be cultured from cardiac blood
indicating C. jejuni bacteremia (Fig. 1C). A molecular survey of
the ileum microbiota composition revealed that concentrations
of total eubacteria, enterobacteria, enterococci and Bacteroides/
Prevotella spp. were increased in T. gondii-induced acute ileitis,
whereas the lactobacilli population was lower as compared to
healthy mice (Fig. 1D). Thus, during acute small intestinal
inflammation accompanied by distinct intestinal microbiota
shifts towards E. coli overgrowth in the GI tract colonization
resistance against C. jejuni is abrogated with hazardous
consequences for the host, as indicated by translocation and
systemic spread of the pathogen.
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to C. jejuni Colonization
Next, we were interested whether colonization resistance against
C. jejuni is also abrogated in mice with chronic intestinal
inflammation accompanied with gut microbiota shifts towards
higher commensal enterobacteria loads [34]. To address this
question we infected 6-months-old IL-10
2/2 mice with chronic
colitis harboring a conventional gut microbiota with C. jejuni
ATCC 43431. Twelve days following oral infection, C. jejuni could
be detected in the ileum and colon (in 55.2% and 69.0% of
infected mice, respectively), but not in the stomach or duodenum
of IL-10
2/2 mice with colitis, whereas healthy wildtype control
animals remained free of C. jejuni (Fig. 2A). Furthermore, the
median C. jejuni loads in infected IL-10
2/2 mice were more than 4
orders of magnitude lower (10
5 CFU/g luminal content) when
compared to mice with T. gondii-induced acute ileitis (Fig. 1A,
2A). Of note, uninfected IL-10
2/2 mice with colitis harbored 4
orders of magnitude higher E. coli counts in their large intestines
when compared to healthy wildtype mice (Fig. 2B). Interestingly,
live C. jejuni could be cultured only from less than 5% (3 out of 67)
of MLNs derived from infected IL-10
2/2 mice, whereas no C.
jejuni at all translocated into spleen, liver, kidney or cardiac blood
at day 12 p.i. (not shown). A molecular survey of the main
bacterial groups within the colonic lumen revealed that IL-10
2/2
Figure 1. C. jejuni colonization along the gastrointestinal tract of mice with T. gondii-induced acute ileitis. Acute ileitis was induced in
conventionally colonized 3-months-old C57BL/6 mice by oral infection with 100 cysts of Toxoplasma gondii ME49 strain. Four days following ileitis
induction, mice were orally infected with C. jejuni strain ATCC 43431 as described in Methods. (A) At day 7 p.i. when T. gondii infected mice display
severe ileitis (ILE) C. jejuni densities in distinct compartments of the gastrointestinal tract were determined by quantification of live C. jejuni in luminal
samples taken from stomach, duodenum, ileum, and colon by cultural analysis (CFU, colony forming units; solid circles) and compared to control mice
without ileitis (Con). (B) E. coli loads in luminal ileum samples of mice with T. gondii-induced acute ileitis (day 7 p.i.; open circles) were compared to
naı ¨ve controls (open diamonds). (C) Relative translocation frequencies (%) of live C. jejuni 43431 ATCC (Cj, black bars) and E. coli (Ec, open bars) were
determined in ex vivo biopsies of mesenteric lymphnodes (MLN), spleen, liver, and blood derived from mice with T. gondii-induced acute ileitis at day
7 p.i. by culture in enrichment broths. (D) A complex molecular analysis of the ileal microbiota composition was assessed in mice with T. gondii-
induced acute ileitis at day 7 p.i. (ILE; solid circles) and compared to naı ¨ve control animals (N; open circles). Main gut bacterial groups were quantified
by Real-Time-PCR analyses amplifying bacterial 16S rRNA variable regions and 16S rRNA gene numbers/ng DNA derived from luminal ileal samples:
Enterobacteriaceae (EB), Enterococci (EC), Lactic acid bacteria (LB), Bifidobacteria (BIF), Bacteroides/Prevotella spp. (BP), Clostridium leptum group (CLEP),
Clostridium coccoides group (CLOCC), Mouse intestinal bacteroidetes (MIB), and total eubacterial load (TL). Numbers of animals harboring C. jejuni or
E. coli out of the total number of analyzed animals are given in parentheses. Medians (black bars), standard deviations and significance levels (P-
values) determined by Mann-Whitney-U test are indicated. Data shown were pooled from at least three independent experiments.
doi:10.1371/journal.pone.0035988.g001
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enterobacteria, Bacteroides/Prevotella spp. and bifidobacteria, where-
as lactobacilli, Clostridium leptum group and mouse intestinal
bacteroidetes rRNA were lower as compared to wildtype controls,
(Fig. 2C). Thus, colonization resistance against C. jejuni is
abrogated by chronic large intestinal inflammation in IL-10
2/2
mice accompanied by distinct changes in colonic microbiota
composition.
C. jejuni Infection of Infant Mice Harboring a
Conventional Intestinal Microbiota
In earlier studies weaned mice harboring a conventional gut
microbiota were shown to be susceptible to C. jejuni infection
[35,36,37,38,39]. Very recently, we could demonstrate that
compared to adult animals, infant mice harbored significantly
higher concentrations of E. coli, Bacteroides/Prevotella spp. and
Clostridium coccoides whereas lactobacilli, bifidobacteria and Clostrid-
ium leptum numbers were lower [40]. To further unravel
immunopathological consequences of abrogated colonization
resistance in infant mice in more detail, we infected 3-weeks-old
animals right after weaning with C. jejuni strains ATCC 43431 or
B2. Adult mice 3 months of age with a common commensal gut
flora served as controls. Kinetic analyses of fecal pathogen burden
revealed that the infant mice harbored higher C. jejuni ATCC
43431 and B2 loads until days 5 and 6 p.i., respectively, when
compared to adult animals (Fig. 3A, B). Interestingly, C. jejuni
strain B2, but not strain ATCC 43431, could stably infect infant
mice until day 6 p.i., as indicated by 66.7% and 30.0% of culture-
positive cases, respectively, with a median load of approximately
10
5 CFU C. jejuni B2/g feces (Fig. 3A, B). Feces samples taken
from naı ¨ve infant mice contained significantly higher numbers of
E. coli (median 10
6 CFU/g), as compared to uninfected adult
animals (Fig. 3C). Thus, these data provide evidence that E. coli
might be causatively involved in the abrogation of murine
colonization resistance against C. jejuni.
The analysis of the clinical outcome revealed that acute
campylobacteriosis was self-limiting in infant mice. A cumulative
score addressing the clinical condition and occurrence of bloody
diarrhea in infected animals revealed that either C. jejuni strain
induced enterocolitis within 24 hours p.i. remaining on a
comparable level until day 6 p.i. (Fig. 3D). C. jejuni infected
infant mice were not severely compromised clinically but
developed mild diarrhea with haemoccult-positive feces irrespec-
tive of the C. jejuni strain analyzed. Furthermore, no live C. jejuni
could be cultured from MLNs, spleen, liver, kidney or cardiac
blood at day 6 following infection with either strain (not shown).
Pro-inflammatory Immune Responses Following C. jejuni
Infection in Infant Mice
Since human campylobacteriosis is accompanied by an influx of
immune cells to the inflamed colon [6,7,8,9], we investigated
numbers of apoptotic cells and immune cells within the colon
mucosa of C. jejuni infected infant mice in situ by immunohisto-
chemistry. Naive infant mice served as controls. At day 6 p.i.,
irrespective of the C. jejuni strain used, infected infant mice
displayed a two-fold increase of apoptotic cells, paralleled by a
significant increase of neutrophilic granulocytes and macrophages
as compared to naive controls (Fig. 4A–C). In addition, both C.
jejuni strains induced multifold increases in T-lymphocytes,
regulatory T-cells (Tregs) as well as B-lymphocytes in infected
versus naı ¨ve infant mice (Fig. 4D–F). The immune cell responses
were accompanied by increased expression of pro-inflammatory
cytokines and mediators in the colon. The levels of nitric oxide,
TNF-a, IL-6, and MCP-1 were significantly higher in colon
biopsies derived from C. jejuni ATCC 43431 and B2 infected mice
at day 6 p.i. as compared to naive controls (Fig. 5A–D). For IFN-
c a significant increase was measured in C. jejuni B2 infected mice
while C. jejuni ATCC 43431 infected mice displayed a trend
towards elevated concentrations (Fig. 5E). Of note, following
infection with either C. jejuni strain, adult mice harboring a
conventional gut microbiota displayed neither clinical signs of
enterocolitis nor relevant immune cell or pro-inflammatory
responses in their colon (also refer to [17]). Taken together, C.
jejuni infection of infant mice resulted in distinct pro-inflammatory
responses and apoptotic changes in the colonic mucosa.
Treatment with Live E. coli Abrogates Murine
Colonization Resistance Against C. jejuni
In order to dissect whether colonization resistance is abrogated
by shifts in the microbiota composition or by conditions of
inflammation we increased intestinal E. coli loads artificially by
treating healthy adult mice with live E. coli in the drinking water
(10
8 CFU/mL) and investigated the susceptibility to C. jejuni
infection. Analysis of E. coli in feces samples revealed that the
intestinal E. coli loads increased by more than 3 orders of
magnitude (from median 10
5 CFU/g to 10
8 CFU/g feces) and
remained stable as long as the E. coli suspension was kept (Fig. 6).
Within 24 hours after withdrawl of the E. coli suspension, the
intestinal E. coli loads decreased back to basal levels (Fig. 6). Oral
infection of E. coli-treated mice and non-treated controls with
C. jejuni strains ATCC 43431 or B2 revealed that E. coli did
significantly increase the colonization capacity of either strain.
(Fig. 7A and B). C. jejuni B2 could be cultured from the entire GI
tract of E. coli treated animals at day 12 p.i. with highest counts in
distal parts such as ileum and colon (Fig. 7C). In non-treated
control animals, however, pathogen burdens were significantly
lower as compared to mice with elevated intestinal E. coli load
(Fig. 7).
Pro-inflammatory Immune Responses in C. jejuni Infected
Adult Mice with Elevated E. coli Loads
To further elucidate whether C. jejuni infection of adult mice
with high intestinal E. coli loads was accompanied by pro-
inflammatory immune responses, we analyzed apoptosis and
inflammatory cells in the colon mucosa by in situ immunohisto-
chemistry. Irrespective of the C. jejuni strain analyzed, infected
mice displayed significantly higher numbers of apoptotic cells,
neutrophils, macrophages, T- and B-lymphocytes as well as
regulatory T-cells in the colon in situ at day 12 p.i. as compared
to non-infected E. coli-treated control animals (Fig. 8).
Secretion of nitric oxide, IL-6, MCP-1, IFN-c and TNF-a in
ex vivo colon biopsies were significantly increased at day 12
following infection with C. jejuni ATCC 43431 or B2 versus naı ¨ve
animals with supra-physiological intestinal E. coli loads (Fig. 9).
Thus, C. jejuni infection of adult mice treated with supra-
physiological E. coli loads is accompanied by pro-inflammatory
immunopathology of the colon. Of note, elevation of intestinal E.
coli loads alone did not affect pro-inflammatory immune responses
(data not shown). This was even true in our recent study when
gnotobiotic mice generated by antibiotic treatment were replen-
ished with a complex human microbiota [17].
Taken together, physiological (infancy) and pathological
conditions (e.g. acute and chronic intestinal inflammation in mice
and men) associated with shifts of the intestinal microbiota
composition such as elevated commensal E. coli loads facilitate C.
jejuni infection inducing or perpetuating immunopathology. Most
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by elevating a single bacterial commensal gram-negative species
such as E. coli within the complex commensal intestinal microbiota
towards supra-physiological levels. These results point towards a
pivotal role of E. coli in facilitating C. jejuni infection.
Discussion
Investigations of the molecular mechanisms underlying C. jejuni
induced immunpathology in vivo are hampered by colonization
resistance of mice due to their host-specific intestinal microbiota
Figure 2. C. jejuni colonization along the gastrointestinal tract of IL-10
2/2 mice with chronic colitis. Conventionally colonized 6-months-
old IL-10
2/2 mice with chronic colitis were orally infected with C. jejuni strain ATCC 43431 as described in Methods. (A) At day 14 p.i. C. jejuni
densities in distinct compartments of the gastrointestinal tract were determined by quantification of live C. jejuni in luminal samples (CFU, colony
forming units; solid circles) taken from stomach, duodenum, ileum, and colon by cultural analysis and compared to wildtype controls (WT, open
circles). (B) Furthermore, E. coli loads in luminal colonic samples of C. jejuni infected IL-10
2/2 mice (IL-10, open circles) were compared to healthy
wildtype control animals (WT, open diamonds). (C) A complex molecular analysis of the colonic microbiota composition was assessed in IL-10
2/2
mice with chronic colitis (IL-10; solid circles) and compared to wildtype control animals (WT; open circles). Main gut bacterial groups were quantified
by Real-Time-PCR analyses amplifying bacterial 16S rRNA variable regions and 16S rRNA gene numbers/ng DNA derived from luminal colonic
samples: Enterobacteriaceae (EB), Enterococci (EC), Lactic acid bacteria (LB), Bifidobacteria (BIF), Bacteroides/Prevotella spp. (BP), Clostridium leptum
group (CLEP), Clostridium coccoides group (CLOCC), Mouse intestinal bacteroidetes (MIB), and total eubacterial load (TL). Numbers of animals
harboring C. jejuni or E. coli out of the total number of analyzed animals are given in parentheses. Medians (black bars) and significance levels (P-
values) determined by Mann-Whitney-U test are indicated. Data shown were pooled from at least three independent experiments.
doi:10.1371/journal.pone.0035988.g002
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bility of an initially resistant host to C. jejuni during acute and
chronic intestinal inflammation. In our acute T. gondii-induced
ileitis model colonization resistance against C. jejuni was
completely abolished and the pathogen colonized the entire GI
tract with high counts. Moreover, C. jejuni and commensal E. coli
translocated into MLNs, spleen, and liver. Strikingly, C. jejuni
could be cultured from cardiac blood samples in .90% of
infected animals displaying severe ileitis indicating bacteremia
and subsequent sepsis. The impact of intestinal inflammation in
overcoming colonization resistance was further supported by the
finding that IL-10
2/2 mice suffering from chronic colitis were
susceptible to C. jejuni infection. This is well in line with previous
findings of Mansfield et al. showing that C. jejuni induced
significant clinical signs of enterocolitis following infection of IL-
10
2/2 mice [41]. However, in the IL-10
2/2 mice analyzed here
Figure 3. Kinetic analyses of C. jejuni colonization in fecal samples of infant mice. Conventionally colonized 3-weeks-old infant (3W; open
circles) and 3-months-old adult (3M; solid circles) mice were orally infected with C. jejuni strain ATCC 43431 (A)o rB 2( B) as described in Methods.
Kinetic analyses of pathogen densities were performed by quantification of live C. jejuni in fecal samples by cultural analysis (CFU, colony forming
units) at day (d) 6 p.i. ** indicates significant differences (p,0.01) of C. jejuni 43431 loads in infected infant mice at d1 versus d3, d5, and d6 p.i. (C) E.
coli loads in colonic samples taken from naı ¨ve 3-weeks-old infant mice (3W, open diamonds) were compared to conventionally colonized 3-months-
old adult mice (3M, open circles). (D) Kinetic analyses of disease activity of conventionally colonized 3-weeks-old infant mice following infection with
C. jejuni strain ATCC 43431 (43431, open circles, n=10) or B2 (solid circles, n=12) were performed applying a standardized clinical score (see
Methods). Numbers of animals harboring C. jejuni or E. coli out of the total number of analyzed animals are given in parentheses. Days past infection,
medians (black bars) and significance levels (P-values) determined by Mann-Whitney-U test are indicated. Data shown were pooled from at least three
independent experiments.
doi:10.1371/journal.pone.0035988.g003
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remained rather subtle. The reason for this discrepancy in colitis
severity is most likely attributed to differences in the genomic
contents of the C. jejuni strains used.
The intestinal inflammation models exerting a compromised
colonization resistance against C. jejuni had all in common
significantly higher E. coli loads at inflamed tissue site, for
instance, when compared to healthy controls with an intact
colonization resistance, irrespective whether the inflammatory
condition was acute or chronic, located in the small or large
intestine. These findings are well in line with results from
previous studies pointing towards a weakness of the physiolog-
ical barrier during intestinal inflammation [19,20,21,42].
Bacteremia and sepsis display hazardous sequelae of C. jejuni
Figure 4. Inflammatory and immune cell responses following C. jejuni infection of infant mice. Conventionally colonized 3-weeks-old
infant mice were orally infected with C. jejuni strain ATCC 43431 (crossed circles) or B2 (solid circles) as described in Methods. The average numbers of
apoptotic cells (positive for caspase-3, panel A), neutrophilic granulocytes (neutrophils, positive for MPO-7, panel B), macrophages (positive for F4/80,
panel C), T-lymphocytes (positive for CD3, panel D), regulatory T-cells (Tregs, positive for FOXP3, panel E) and B-lymphocytes (positive for B220, panel
F) from at least six high power fields (HPF,6400 magnification) per animal were determined microscopically in immunohistochemically stained colon
sections at day 6 p.i. Uninfected mice (Naı ¨ve, open circles) served as negative controls. Numbers of analyzed animals are given in parentheses. Means
(black bars) and levels of significance (P-values) determined by the Student’s t-test are indicated. Data shown are representative for three
independent experiments.
doi:10.1371/journal.pone.0035988.g004
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(e.g. Crohn’s disease patients with acute episodes). A high
prevalence of C. concisus was recently detected in paediatric CD
as well as adult UC patients [43,44]. Although distinct from
IBD, irritable bowel syndrome was described to occur as a
potential post-infectious event following C. jejuni infection [45].
Taken together, these findings once more point towards a
correlation between inflammation, intestinal microbiota and
susceptibility to C. jejuni infection.
Given that colonization of the intestinal tract starts right after
birth and complexity increases thereafter, the question arises
whether infant mice already display a fully established
colonization resistance. Neonatal mice had been used in
Campylobacter research already three decades ago, investigating
transmissibility from infant to dam, virulence factors, vaccines
and the efficacy of bismuth subsalicylate in preventing the
growth and colonization of the intestinal tract [35,36,37,39,46].
Remarkably, infection of 3-weeks-old mice right after weaning
in our study revealed that C. jejuni B2, and to a less distinct
extent strain ATCC 43431, could stably colonize the GI tract of
mice. Moreover, infant mice displayed approximately 2–3
orders of magnitude higher E. coli counts in their feces as
compared to 3-months-old adult animals. Thus, there is
evidence that an altered microbiota towards higher enterobac-
teria numbers (such as E. coli) might facilitate C. jejuni infection.
When assessing C. jejuni induced clinical pathology due to blood-
Figure 5. Pro-inflammatory cytokine responses in the colon of C. jejuni infected infant mice. Conventionally colonized 3-weeks-old infant
mice were orally infected with C. jejuni strain ATCC 43431 (43431, crossed circles) or B2 (solid circles) as described in Methods. Concentrations (pg per
mg colon) of (A) nitric oxide, (B) TNF-a,( C) IL-6, (D) MCP-1, and (E) IFN-c were determined in supernatants of ex vivo colon cultures at day 6 p.i. by
Griess reaction or CBA-ELISA, respectively. Uninfected mice (Naı ¨ve, open circles) served as negative controls. Numbers of analyzed animals are given
in parentheses. Means (black bars) and levels of significance (P-values) as compared to the respective group (determined by Student’s t-test) are
indicated. Data shown are representative for three independent experiments.
doi:10.1371/journal.pone.0035988.g005
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following infection, the clinical outcomes were similar in infant
mice infected with C. jejuni strains B2 or ATCC 43431. Both
strains originate from humans with severe enteritis, are invasive
in vitro and induced distinct pro-inflammatory immune responses
within the colon mucosa of C. jejuni infected infant mice. The
elevated intestinal E. coli loads in mice suffering from intestinal
inflammation and in infant mice provide evidence that E. coli is
essentially involved in abrogation of CR. This is further
underlined by a substantially increased colonization capacity of
C. jejuni in adult mice in which the commensal intestinal
microbiota was artificially modified towards supra-physiological
intestinal E. coli loads. This finding demonstrates again that CR
against C. jejuni is mediated by the microbiota and that shifts in
the flora represent a risk for C. jejuni infection.
We conclude that the murine models of C. jejuni infection
presented here shed further lights into the mechanisms underlying
CR against C. jejuni offering promising tools to further unravel the
interplay between intestinal pathogens, gut microbiota and the
innate and adaptive immune system.
Figure 6. E. coli loads of adult mice following application of E. coli via drinking water. In conventionally colonized 3-months-old adult mice
(n=6) intestinal E. coli loads were raised by adding live E. coli into the drinking water (+ E. coli, until day 8) as described in Methods. At day 8, the
E. coli suspension was withdrawn and replaced by regular tap water. Kinetic analyses of E. coli densities were performed by quantification of live
bacteria in fecal samples by cultural analysis (CFU, colony forming units) until day 13 p.i. Medians (black bars) and levels of significance (P-values) as
compared to the indicated groups (determined by Mann-Whitney-U test) are indicated. Data shown are representative for three independent
experiments.
doi:10.1371/journal.pone.0035988.g006
Figure 7. Time course of C. jejuni colonization in adult mice with increased E. coli loads. In conventionally colonized 3-months-old adult
mice intestinal E. coli loads were raised up to 10
8 bacteria per gram feces by adding live E. coli into the drinking water (+ E. coli) as described in
Methods. Mice were orally infected with C. jejuni strain ATCC 43431 (A)o rB 2( B). Kinetic analyses of pathogen densities were performed by
quantification of live C. jejuni in fecal samples derived from mice with elevated (Ec; solid circles) or normal (N; open circles) E. coli loads by cultural
analysis (CFU, colony forming units) until day 12 p.i. (C) C. jejuni B2 densities in distinct compartments of the gastrointestinal tract were determined in
luminal samples taken from stomach, duodenum, ileum, and colon of mice with elevated (Ec; solid circles) or normal (N; open circles) E. coli loads at
day 12 p.i. Numbers of animals harboring C. jejuni out of the total number of analyzed animals are given in parentheses. Days post infection,
medians (black bars) and levels of significance (P-values) as compared to the respective group (determined by Mann-Whitney-U test) are indicated.
Data shown are pooled from at least three independent experiments.
doi:10.1371/journal.pone.0035988.g007
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e35988Figure 8. Immune responses following C. jejuni infection of adult mice with increased E. coli loads. In conventionally colonized 3-months-
old adult mice intestinal E. coli loads were raised up to 10
8 bacteria per gram feces by adding live E. coli into the drinking water (+ E. coli) as described
in Methods. Then, mice were orally infected with C. jejuni strain ATCC 43431 (crossed circles) or B2 (solid circles). The average numbers of apoptotic
cells (positive for caspase-3, panel A), neutrophilic granulocytes (Neutrophils, positive for MPO-7, panel B), macrophages (positive for F4/80, panel C),
T-lymphocytes (positive for CD3, panel D), regulatory T-cells (Tregs, positive for FOXP3, panel E) and B-lymphocytes (positive for B220, panel F) from
at least six high power fields (HPF, 4006magnification) per animal were determined microscopically in immunohistochemically stained colon sections
at day 12 p.i. Uninfected mice (Naı ¨ve, open circles) served as negative controls. Numbers of analyzed animals are given in parentheses. Means (black
bars) and levels of significance (P-values) as compared to uninfected (Naı ¨ve) control mice (determined by the Student’s t-test) are indicated. Data
shown are pooled from at least three independent experiments.
doi:10.1371/journal.pone.0035988.g008
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Ethics Statement
Animal experiments were conducted according to the European
Guidelines for animal welfare (2010/63/EU) with approval of the
commission for animal experiments headed by the ‘‘Landesamt fu ¨r
Gesundheit und Soziales’’ (LaGeSo, Berlin, Germany; Registra-
tion numbers: G0173/07 and G135/10). Animal welfare was
monitored twice daily by assessment of clinical conditions.
Mice
Mice were bred and maintained in the facilities of the
‘‘Forschungsinstitut fu ¨r Experimentelle Medizin’’ (FEM, Charite ´
- Universita ¨tsmedizin, Berlin, Germany), under specific pathogen-
Figure 9. Colonic pro-inflammatory cytokine responses of C. jejuni infected adult mice with increased E. coli loads. In conventionally
colonized 3-months-old adult mice intestinal E. coli loads were raised up to 10
8 bacteria per gram feces by adding live E. coli into the drinking water (+
E. coli) as described in Methods. Then, mice were orally infected with C. jejuni strain ATCC 43431 (crossed circles) or B2 (solid circles). Concentrations
(pg per mg colon) of (A) nitric oxide, (B) IL-6, (C) MCP-1, (D) IFN-c, and (E) TNF-a were determined in supernatants of ex vivo colon cultures at day
12 p.i. by Griess reaction or CBA-ELISA, respectively. Uninfected mice (Naı ¨ve, open circles) served as negative controls. Numbers of analyzed animals
are given in parentheses. Means (black bars) and levels of significance (P-values) as compared to the uninfected (Naı ¨ve) group determined by
Student’s t-test are indicated. Data shown were pooled from at least three independent experiments.
doi:10.1371/journal.pone.0035988.g009
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experiments. Age matched female mice 3 weeks (right after
weaning; infant mice) and 3 months of age (adult mice) as well as
6 months old IL-10
2/2 mice (C57BL/6 background) with overt
chronic colitis were used.
Clinical Score
To assess clinical/macroscopic signs of C. jejuni induced
infection on a daily basis, a standardized cumulative clinical score
(maximum 12 points; modified according to [47] addressing the
occurrence of blood in feces (0 points: no blood; 2 points:
microscopic detection of blood by the Guajac method using
Haemoccult, Beckman Coulter/PCD, Krefeld, Germany; 4
points: macroscopic blood visible), diarrhea (0: formed feces; 2:
pasty feces; 4: liquid feces), and the clinical aspect (0: normal; 2:
ruffled fur, less locomotion; 4: isolation, severely compromized
locomotion, pre-final aspect) was used.
Induction of Acute Ileitis
For induction of ileitis, C57BL/6 mice were infected orally with
100 Toxoplasma (T.) gondii cysts (ME49 strain) from homogenized
brains of intraperitoneally infected NMRI mice in a volume of
0.3 ml phosphate-buffered saline (PBS, pH 7.4) by gavage, as
described previously [22,23,48,49].
C. jejuni Infection of Mice
Mice were infected with approximately 10
9 viable CFU of C.
jejuni strains ATCC 43431 or B2 by gavage in a total volume of
0.3 mL PBS on two consecutive days as described earlier in detail
[17]. C. jejuni strain B2 was kindly provided by Prof. Dr. Uwe
Groß, University of Go ¨ttingen, Germany.
Elevation of Intestinal E. coli Loads
In order to raise intestinal E. coli loads in 3-months-old adult
mice harboring a conventional gut microbiota to supra-physiologic
levels, live E. coli were isolated from naı ¨ve, healthy 3 months old
C57BL/6 mice by culture on MacConkey media. This strain was
shown to be a common commensal in healthy mice. PCR-based
detection revealed that this strain does not contain known
virulence factors of pathogenic E. coli such as stx 1 and 2, catA,
hlyA, cspA, katP, and astA. This commensal E. coli strain was
subcultivated on blood agar and added to the drinking water at a
final concentration of 10
8 CFU per mL suspension starting at day
0 in naı ¨ve animals. The E. coli suspension was renewed daily. For
kinetic experiments, the E. coli suspension was withdrawn after
8 days and replaced by regular tap water thereafter. For C. jejuni
infection studies, the application of E. coli in drinking water was
started 8 days prior the first oral C. jejuni infection and continued
until the end of the experiment (12 days following the latest
C. jejuni gavage).
Sampling Procedures, Determination of Colon Length
and Histopathology
Mice were sacrificed by isofluran treatment (Abbott, Germany).
From each mouse samples derived from the GI tract (stomach,
duodenum, ileum, colon) were collected in parallel for histological,
microbiological, immunobiological and molecular analyses. Car-
diac blood and tissue samples from mesenteric lymphnodes,
spleen, liver and the GI tract were asserved under sterile
conditions. Histopathological changes were determined in colon
samples immediately fixed in 5% formalin and embedded in
paraffin. Sections (5 mm) were stained with respective antibodies
for immunohistochemistry.
Immunohistochemistry
In situ immunohistochemical analysis of colonic paraffin sections
were performed as described previously [17,24,50]. Primary
antibodies against CD3 (#N1580, Dako, Denmark, dilution
1:10), FOXP-3 (FJK-16s, eBioscience, 1:100), B220 (eBioscience,
San Diego, CA, USA, 1:200), myeloperoxidase-7 (MPO-7, #
A0398, Dako, 1:400), F4/80 (#14–4801, clone BM8, eBioscience,
1:50), and cleaved caspase-3 (Asp175, Cell Signaling, USA, 1:200)
were used. For each animal, the average number of positive
stained cells within at least six independent high power fields
(HPF, 4006magnification) were determined microscopically and
subjected to statistical analysis as indicated.
Cytokine Detection in Colon Culture Supernatants
Colon biopsies were cut longitudinally, washed in PBS and
strips of 1 cm
2 placed in 24-flat-bottom well culture plates (Nunc,
Wiesbaden, Germany) containing 500 ml serum-free RPMI 1640
medium supplemented with penicillin (100 U/ml) and streptomy-
cin (100 ug/ml; PAA Laboratories). After 18 h at 37uC, culture
supernatants were tested for TNF-a, IL-6, MCP-1 and IFN-c by
the Mouse Inflammation Cytometric Bead Assay (CBA; BD
Biosciences) on a BD FACSCanto II flow cytometer (BD
Biosciences). Nitric oxide (NO) was determined by Griess-reaction
as described earlier [22].
Analysis of the Intestinal Microflora
Cultural analyses, biochemical identification and molecular
detection of luminal bacterial communities from stomach,
duodenum, ileum, and colon as well as feces were performed as
previously described [17,22,23,24].
Assessment of Bacterial Translocation Frequencies
For bacterial translocation experiments, mesenteric lymphnodes
(MLNs) draining the small intestine, spleen, liver (1 cm
2) and
cardiac blood (1 mL) were transferred into thioglycollate enrich-
ment broths under sterile conditions and cultivated for 7 days.
Turbid broths were streaked onto sheep blood, MacConkey as
well as Karmali agar in order to detect translocated live E. coli and
C. jejuni followed by biochemical species identification (API 20E
and API Campy, respectively, Biome ´rieux). Given that bacterial
growth in enrichment broths cannot be quantitated, the relative
rates of translocating C. jejuni or E. coli into the respective extra-
intestinal compartment are expressed in % (number of broths
culture-positive for either E. coli or C. jejuni multiplied with 100 and
divided by the total number of broths inoculated with the
respective organ or blood).
Statistical Analysis
Mean values, medians, standard deviations, and levels of
significance were determined using appropriate tests as indicated
(two-tailed Student’s t-Test, Mann-Whitney-U Test). Two-sided
probability (P) values #0.05 were considered significant. All
experiments were repeated at least twice.
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